Viewing StudyNCT00004852



Ignite Creation Date: 2024-05-05 @ 10:00 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00004852
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 2000-03-02

Brief Title: Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs
Sponsor: Glaxo Wellcome
Organization: NIH AIDS Clinical Trials Information Service

Conditions & Keywords Data

Conditions:
Name
HIV Infections
Keywords:
Name View
efavirenz View
HIV-1 View
Drug Therapy Combination View
Zidovudine View
Drug Administration Schedule View
Lamivudine View
Genotype View
Phenotype View
Reverse Transcriptase Inhibitors View
Anti-HIV Agents View
Viral Load View